Wells Fargo Cuts Valuation Range on Protalix BioTherapeutics (PLX), Comments on Taliglucerase Delay
Go back to Wells Fargo Cuts Valuation Range on Protalix BioTherapeutics (PLX), Comments on Taliglucerase Delay| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.34 +0.05 (2.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.29 | 52 Week High | $1.11 | |||
| Open | $2.30 | 52 Week Low | $0.41 | |||
| Day High | $2.35 | P/E | N/A | |||
| Day Low | $2.28 | EPS | $-0.29 | |||
| Volume | 280,467 | |||||
